Diabetes Innovations Unveiled
Kevin shares groundbreaking data on CGM benefits for type two patients and pediatric users. Scott praises John's detailed explanation of standard deviation and coefficient of variation, emphasizing their impact on managing lows. Kevin and Scott reflect on the endless learning opportunities in the field.In this clip
From this podcast

Juicebox Podcast: Type 1 Diabetes
#345 Dexcom CEO Returns
Related Questions